Egaten

Active Ingredient(s): Triclabendazole
FDA Approved: * February 13, 2019
Pharm Company: * NOVARTIS PHARMS CORP
Category: Antiprotozoal / Anthelmintic

Triclabendazole, sold under the brand name Egaten among others, is a medication used to treat fascioliasis and paragonimiasis.[1] It is very effective for both conditions.[1] Treatment in hospital may be required.[1] It is taken by mouth with typically one or two doses being required.[1] Side effects are generally few, but can include abdominal pain and headaches.[1] Biliary colic may occur due to dying worms.&... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Egaten 250 mg Oral Tablet
NDC: 0078-0937
Labeler:
Novartis Pharmaceuticals Corporation